Hypofractionated IMRT With Temozolomide for HGG
type: MedicalStudy
description: Hypofractionated IMRT (VMAT-RA) With Temozolomide for Patients With Newly Diagnosed High Grade Glioma (HGG)
status: COMPLETED
study design: INTERVENTIONAL
phase: NA
start date: 2013-07
end date: 2016-05
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT02082119
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Istituto Clinico Humanitas
study subject: Glioma
keywords: NA
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Glioma

AI Analytics
type: Organization